These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7926343)

  • 21. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.
    Kark JD; Sandholzer C; Friedlander Y; Utermann G
    Atherosclerosis; 1993 Jan; 98(2):139-51. PubMed ID: 8457257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.
    Suzuki T; Futami-Suda S; Igari Y; Watanabe K; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H; Oba K
    Lipids Health Dis; 2013 Mar; 12():31. PubMed ID: 23496967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
    Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
    Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM.
    Velho G; Erlich D; Turpin E; Néel D; Cohen D; Froguel P; Passa P
    Diabetes Care; 1993 May; 16(5):742-7. PubMed ID: 8495614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO
    Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
    Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
    Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus.
    Cömlekçi A; Biberoglu S; Kozan O; Bahçeci O; Ergene O; Nazli C; Kinay O; Güner G
    J Intern Med; 1997 Dec; 242(6):449-54. PubMed ID: 9437405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
    J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
    Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
    Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
    Shi H; Fang J; Yang X; Shen Z; Zhu X
    Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.